PCN73 Cost-Effectiveness of Pembrolizumab Versus Chemotherapy for Advanced Esophageal Squamous Cell Carcinoma (ESCC) As the Second-LINE Treatment Among the Chinese Population

Jun 1, 2021, 00:00
10.1016/j.jval.2021.04.165
https://www.valueinhealthjournal.com/article/S1098-3015(21)00382-X/fulltext
Title : PCN73 Cost-Effectiveness of Pembrolizumab Versus Chemotherapy for Advanced Esophageal Squamous Cell Carcinoma (ESCC) As the Second-LINE Treatment Among the Chinese Population
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)00382-X&doi=10.1016/j.jval.2021.04.165
First page :
Section Title :
Open access? : No
Section Order : 10743
Categories :
Tags :
Regions :
ViH Article Tags :